• Anuttam Kuila Department of Pharmaceutics, JSS College of Pharmacy, Ootacamund, JSS Academy of Higher Education and Research, Mysuru - 643 001, India.
  • Nagasamy Venkatesh Dhandapani Department of Pharmaceutics, JSS College of Pharmacy, Ootacamund, JSS Academy of Higher Education and Research, Mysuru - 643 001, India.
  • Himangshu Bhowmik Department of Pharmaceutics, JSS College of Pharmacy, Ootacamund, JSS Academy of Higher Education and Research, Mysuru - 643 001, India.
  • Abhishek Soni Department of Pharmaceutics, JSS College of Pharmacy, Ootacamund, JSS Academy of Higher Education and Research, Mysuru - 643 001, India.
  • Kammari Harish Kumar Department of Pharmaceutics, JSS College of Pharmacy, Ootacamund, JSS Academy of Higher Education and Research, Mysuru - 643 001, India.


The research on chronotherapy has garnered interest from scientists to understand circadian rhythms and their applications in the biological system. The area of chronotherapeutics covers essential information which is helpful to move forward and solve entanglements in current drug delivery technology. Chronotherapy is the conveying drugs in the body at the target site by maintaining perfect synchronicity with circadian rhythms. The main aim of the current rhythmic research is to formulate and design a therapeutic novel system which can deliver the drug in a desired way inside the body to treat various rhythmic diseases according to their occurrence. Drug release from an ideal chronotherapeutic system should be rapid, and the release of drug from the delivery system should also be complete after a specific or defined lag time period. Recently, scientists are involved in developing chronotherapeutic drug delivery system to treat chronological diseases such as single and multiple units using an erodible, soluble or insoluble polymer coating, and stimuli regulated drug delivery systems. In this review, we focus on the elaboration of the concept of chronotherapy, main challenges ahead during its development process, current approaches and its future applications in drug delivery in the treatment of circadian rhythmic diseases.

Keywords: Circadian rhythms, Chronotherapy, Pulsatile drug delivery, Lag time, Stimuli.


1. Sewlall S, Pillay V, Danckwerts P, Choonara EY, Ndesendo MK, Du Toit LC. A timely review of state-of-the-art chronopharmaceuticals synchronized with biological rhythms. Curr Drug Deliv 2010;7:370-88.
2. Schibler U. The daily rhythms of genes, cells, and organs. EMBO Rep 2005;6:9-13.
3. Oishi K, Ohkura N, Kadota K, Kasamatsu M, Shibusawa K, Matsuda J, et al. Clock mutation affects circadian regulation of circulating blood cells. J Circadian Rhythms 2006;4:1-7.
4. Froy O. The relationship between nutrition and circadian rhythms in mammals. Front Neuroendocrinol 2007;28:61-71.
5. Beckett M, Rode LC. Mechanisms by which circadian rhythm disruption may lead to cancer. S Afr J Sci 2009;105:11-2.
6. Rana S, Mahmood S. Circadian rhythm and its role in malignancy. J Circadian Rhythms 2010;8:1-13.
7. Mazuski C, Herzog ED. Circadian rhythms: To sync or not to sync. Curr Biol 2015;25:337-9.
8. Romano S, Chacko SJ, Rangarajan V, Chung J, Farzaneh AF. Resistant hypertension. Am J Med 2015;128:23-5.
9. Chen K, Wang Y, Gai X, Wang H, Li Y, Wen H, et al. Design of a time-controlled pulsatile release system for propranolol using the dry-coated method: In vitro and in vivo evaluation. AAPS Pharm Sci Tech 2017;18:2683-90.
10. Hong YJ, Jeong MH, Cho KH, Kim MC, Lee KJ, Kim KH, et al. Impact of renal function on changes of plaque characteristics in non-intervened coronary segments after rosuvastatin treatment in patients with angina pectoris and hypertension. Int J Cardiol 2015;187:286-7.
11. Thitinan S, Mc Conville JT. Development of a gastroretentive pulsatile drug delivery platform. J Pharm Pharmacol 2012;64:505-16.
12. Arafat MO. Approaches to achieve an oral controlled release drug delivery system using polymers: A recent review. Int J Pharm Pharm Sci 2015;7:16-21.
13. Shishehbori F, Mortazavia SA, Jafariazar Z, Rad RT. Formulation and in vitro evaluation of ketoprofen gastric floating matrix tablet based on gas formation. Int J Appl Biol Pharm 2015;6:85-93.
14. Gandhi S, Gosse MD, Nishii Y, Nuxoll E. Barrier-mediated pulsatile release. J Membr Sci 2015;495:351-60.
15. Shidhaye S, Lotlikar V, Ghule A, Phutane P, Kadam V. Pulsatile delivery systems: An approach for chronotherapeutic diseases. Sys Rev Pharm 2010;1:55.
16. Vemula SK. Formulation and pharmacokinetics of colon-specific double-compression coated mini-tablets: Chronopharmaceutical delivery of ketorolac tromethamine. Int J Pharm 2015;491:35-41.
17. Parmar RD, Parikh RK, Vidyasagar G, Patel DV, Patel CJ, Patel BD. Pulsatile drug delivery systems: An overview. Int J Pharm Sci Nanotech 2009;2:6-5.
18. Jain SS, Agarwal HV, Jagtap PS, Dand NM, Jadhav KR, Kadam VJ. Pulsatile drug delivery system (PDDS): A Brief overview. Res J Pharm Technol 2012;5:449-61.
19. Saigal N, Baboota S, Ahuja A, Ali J. Site-specific chronotherapeutic drug delivery systems: A patent review. Recent Pat Drug Deliv 2009;3:64-70.
20. Patel MM. Colon: A gateway for chronotherapeutic drug delivery systems. Expert Opin Drug Deliv 2015;12:1389-95.
21. Rompicharla B, Prabha KS, Tabasum MD. A comprehensive review of pulsatile drug delivery system. Int Res J Pharm 2012;3:106-8.
22. Gupta A. Review on recent advances in pulsatile drug delivery system: A vision for better future for treatment of diseases. Int Pharm Sci 2012;2:71-6.
23. Gandhi BR, Mundada AS, Gandhi PP. Chronopharmaceutics: As a clinically relevant drug delivery system. Drug Deliv 2011;18:1-8.
24. Sangalli ME, Maroni A, Zema L, Busetti C, Giordano F, Gazzaniga A. In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery. J Control Release 2001;73:103-110.
25. Singh V, Deshpande A. The emergence of time programmed drug delivery system: Chronotherapy of cardiovascular diseases. Int J Pharm Pharm Sci 2014;6:56-60.
26. Ueda Y, Hata T, Yamaguchi H, Ueda S, Kodani M, inventors; Fujisawa Pharmaceutical Co Ltd, assignee. Time-Controlled Explosion Systems and Processes for Preparing the Same. United States patent US 4,871,549; 1989.
27. Kok PH, Vonk P, Kossen NW. A particulate pulse-release system and mathematical description with the Maxwell–Stefan theory. J Control Release 2000;66:293-306.
28. Gazzaniga A, Busetti C, Moro L, Crimella T, Sangalli M, Giordano F. Evaluation of low viscosity HPMC as retarding coating material in the preparation of time-based oral colon-specific delivery system. Proc Int Symp Control Release Bioact Mater 1995;22:242-3.
29. Narisawa S, Nagata M, Danyoshi C, Yoshino H, Murata K, Hirakawa Y, et al. An organic acid induced sigmoidal release system for oral controlled release preparation. Pharm Res 1993;11:111-6.
30. Badve SS, Sher P, Korde A, Pawar AP. Development of hollow/porous calcium pectinate beads for floating-pulsatile drug delivery. Eur J Pharm Biopharm 2007;65:85-93.
31. Pawar VK, Awasthi R. Chronotherapy: An approach to synchronize drug delivery with circadian rhythm. J Chronother Drug Deliv 2010;1:1-8.
32. Singh DK, Poddar AS, Nigade SU, Poddar SS. Pulsatile drug delivery system: An overview. Int J Curr Pharm Res 2011;2:55-80.
33. Nagar M, Singhai S, Chopra VS, Gautam N, Trivedi P. Chronotropic systems; an emerging trend in drug delivery for pulsed release in chronopharmacotherapy. Int J Pharm Clin Res 2010;2:10-9.
34. Ashwini D, Asif K, Ramana MV, Mitul P, Omkar D. Chronotherapy: A novel drug delivery system. Int J Res Ayurveda Pharm 2011;2:1692 700.
35. Shanmugan P, Bandameedi R. Chronotherapeutic drug delivery systems. J Drug Metab Toxicol 2015;6:2.
36. Jain D, Raturi R, Jain V, Jain V, Bansal P, Singh R. Recent technologies in pulsatile drug delivery systems. Biomatter 2011;1:57-65.
37. Maroni A, Sangalli ME, Cerea M, Busetti C, Giordano F, Gazzaniga A. Low viscosity HPMC coating of soft and hard gelatin capsules for delayed and colonic release: Preliminary investigations on process parameters and in vitro release performances. Proceed. Int Control Rel Bioact Mater 1999;26:87-8.
38. Nawle RB, Tadvee AA. Formulation and evaluation of time-release compression coated tablet containing acebrophylline for chronotherapy of asthma. Int J Pharm Pharm Sci 2014;6:231-7.
39. Youan BB. Chronopharmaceutical drug delivery systems: Hurdles, hype or hope? Adv Drug Deliv Rev 2010;62:898-903.
40. Langer R, Tirrell DA. Designing materials for biology and medicine. Nat 2004;428:487-92.
41. Koschwanez HE, Reichert WM. In vitro, in vivo and post explantation testing of glucose-detecting biosensors: Current methods and recommendations. Biomaterials 2007;28:3687-703.
42. Goldbeter A. Computational approaches to cellular rhythms. Nat 2002;420:238-45.
43. Youan BB. Chronopharmaceutics: Science and Technology for Biological Rhythm Guided Therapy and Prevention of Diseases. New Jersey: John Wiley and Sons; 2009. p. 384.
44. Midha KK, McKay G. Bioequivalence; Its history, practice, and future. AAPS J 2009;11:664-70.
45. Philip KA, Philip B. Chronopharmaceuticals: Hype or future of pharmaceutics. Curr Pharm Des 2011;17:1512-6.
46. Klasmeier C, Redish MH. Off-label prescription advertising, the FDA and the first amendment: A study in the values of commercial speech protection. Am J Law Med 2011;37:315-57.
47. Youan BB. Chronopharmaceutics: Gimmick or clinically relevant approach to drug delivery? J Control Release 2004;98:337-53.
48. Mandal AS, Biswas N, Karim KM, Guha A, Chatterjee S, Behera M, et al. Drug delivery system based on chronobiology-A review. J Control Release 2010;147:314-25.
49. Youan BB. Impact of nanoscience and nanotechnology on controlled drug delivery. Nanomed 2008;3:401-6.
116 Views | 309 Downloads
How to Cite
Kuila, A., N. V. Dhandapani, H. Bhowmik, A. Soni, and K. H. Kumar. “CHRONOTHERAPEUTIC DRUG DELIVERY SYSTEM: AN EMERGING APPROACH TO TREAT CIRCADIAN RHYTHMIC RELATED DISEASE”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 11, no. 8, Aug. 2018, pp. 15-20, doi:10.22159/ajpcr.2018.v11i8.26169.
Review Article(s)